• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number VAMF4040C150TJ
Device Problem Inaccurate Delivery (2339)
Patient Problems Death (1802); Occlusion (1984); Vascular Dissection (3160)
Event Date 01/06/2014
Event Type  Death  
Event Description
A valiant stent graft system was implanted for the endovascular treatment of a 6.8 cm diameter thoracic aortic aneurysm in zone one.The proximal neck was 37 mm and the distal neck was 32 mm in diameter.The aortic neck length was 42 mm.There was mild calcification at the superficial femoral artery.It was reported that approximately four months after the index procedure, the patient expired due to an ascending aortic dissection which was confirmed by a ct check.Two months post implant, a follow up ct was taken and no observations were seen.The physician commented that it is unknown the direct causality with the valiant devices.Film review analysis: review of returned angio images at implant showed the taa just distal to the lsa in the arch.The proximal main device was implanted just distal to the brachiocephalic, and a proximal cuff was placed several mm's proximal to the main device.The lsa was then coiled.Both sets of bare springs were positioned near to the level of the brachiocephalic ostium.No stent graft issues were observed.Cta's from 3-months post-implant showed no stent graft issues or endoleaks.No dissection was seen.The max diameter taa was approximately 6cm.Cta's from 5-months post-implant were non-contrast; the reported type a dissection could not be assessed due to the limited films.No obvious stent graft issues could be confirmed.The cause of the type a retrograde dissection could not be determined.It is possible that the implant of the stent graft into zone 1 may have contributed.
 
Manufacturer Narrative
(b)(4).Evaluation method: (film).Evaluation results and conclusion: (dissection, death).(unknown cause of event).(implanting in zone one).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
ludmila voulfson
3576 unocal place
santa rosa, CA 95403
7075661229
MDR Report Key3600917
MDR Text Key4158410
Report Number2953200-2014-00144
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2015
Device Catalogue NumberVAMF4040C150TJ
Device Lot NumberV04003489
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/10/2014
Initial Date FDA Received01/30/2014
Date Device Manufactured03/05/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age00069 YR
-
-